Have a feature idea you'd love to see implemented? Let us know!
Back to PTGX overview

PTGX Protagonist Therapeutics PE ratio, current and historical analysis

  1. Stocks
  2. Healthcare
  3. NASDAQ: PTGX
  4. PE Ratio

As at Dec 24, 2024, the PTGX stock has a PE ratio of 13.6. This is based on the current EPS of $2.89 and the stock price of $39.3 per share.

PTGX PE ratio history

How has PTGX's PE ratio performed in the past

The mean historical PE ratio of Protagonist Therapeutics over the last eight years is 22.41. The current 13.6 PE ratio is 39% below the historical average. Over the past eight years, PTGX's PE ratio was at its highest in the Jun 2017 quarter at 51.41, with a price of $11.31 and an EPS of $0.22. The Mar 2024 quarter recorded the bottom point at 10.84, with a price of $28.93 and an EPS of $2.67.

Average
22.41
Median
15.57
Minimum
10.84
Maximum
51.41

Protagonist Therapeutics PE ratio by year

Year PE ratio Change
2023 N/A N/A
2022 N/A N/A
2021 N/A N/A
2020 N/A N/A
2019 N/A N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

PTGX average PE ratio chart

What is the average PE ratio of PTGX for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

PTGX PE vs peers

What is PTGX's PE ratio compared to its peers

Compared to its peer stock ORMP, PTGX's PE ratio stands lower.

Stock name PE ratio Market cap
PTGX Protagonist Therapeutics Inc 13.67 $2.35B
ORMP Oramed Pharmaceuticals Inc 21.45 $95.14M
OLMA Olema Pharmaceuticals Inc N/A $362.12M
OMER Omeros Corp N/A $606.15M
OMGA Omega Therapeutics Inc N/A $45.51M
ONVO Organovo Holdings Inc N/A $5.22M
ORIC Oric Pharmaceuticals Inc N/A $589.23M

Frequently asked questions

What is Protagonist Therapeutics's PE ratio?

The price to earnings ratio for PTGX stock is 13.6 as of Dec 24, 2024.

What is the highest PE ratio for PTGX?

The highest quarterly PE ratio in the last eight years has been 51.41 and it was in the Jun 2017 quarter.

How does the current PE ratio for PTGX compare to its historical average?

PTGX's current price to earnings ratio is 39% below its 8-year historical average.

How is PTGX's PE ratio calculated (Protagonist Therapeutics PE ratio formula)?

To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Dec 24, 2024), Protagonist Therapeutics's stock price is $39.3. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $2.89. Therefore, Protagonist Therapeutics's P/E ratio for today is 13.6. PE RATIO(13.6) = STOCK PRICE($39.3) / TTM EPS($2.89)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.